共 7 条
[1]
A phase multi-center study of oral lobucivir for chronic hepatitis B. Heathcote J,Chan R,McLintchson J,et al. Hepatology . 1998
[2]
Two year lamivudine therapy in chronic hepatitis B infections results of aplacebo controlled multicentre study in Asia. Liaw YF,Lai CL,Leung NWY,et al. Gastroenterologia . 1998
[3]
DNA vaccine. Lai WC,Bennett M. Critical Reviews in Immunology . 1998
[4]
An open comparativestudy of lamivudine and famiciclovir in the treatment ofchronic hepatitis B. Lai CL,Yuen MF,Cheng CC,et al. Hepatology . 1998
[5]
The interferon receptors. Polka S. Seminars in Oncology . 1997
[6]
Molecular andbiologic characterization of recombinant interferon-a2b. l Bordens R,Grossberg SE,Trotta PP,et al. Seminars in Oncology . 1997
[7]
Loss of serum HBVDNA and HBeAg and seroconversion following short-term(12 weeks) adefovir dipivoxil therapy in chronic hepatitis B:two placebo-controlled phase n studies. Heathcote EJ,Jeffer L,Wright J,ac al. Hepatology . 1998